All Stories

  1. Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer’s Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer’s Disease
  2. Homocysteine metabolites inhibit autophagy, elevate amyloid beta, and induce neuropathy by impairing Phf8/H4K20me1‐dependent epigenetic regulation of mTOR in cystathionine β‐synthase‐deficient mice
  3. Homocysteine Metabolites Impair the Phf8/H4K20me1/mTOR/Autophagy Pathway by Upregulating the Expression of PHF8-targeting miR-22-3p and miR-1229-3p in Human Vascular Endothelial Cells
  4. Proteomic Exploration of Paraoxonase 1 Function in Health and Disease
  5. Homocysteine Metabolites Inhibit Autophagy and Elevate Amyloid Beta by Impairing Phf8/H4K20me1-dependent Epigenetic Regulation of mTOR in Cystathionine β-Synthase-Deficient Mice
  6. Depletion of bleomycin hydrolase (Blmh) downregulates histone demethylase Phf8, impairs mTOR signaling/autophagy, accelerates amyloid beta accumulation, and induces neurological deficits in mice
  7. Depletion of Paraoxonase 1 (Pon1) Dysregulates mTOR, Autophagy, and Accelerates Amyloid Beta Accumulation in Mice
  8. Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
  9. Cystathionine β‐synthase gene inactivation dysregulates major urinary protein biogenesis and impairs sexual signaling in mice
  10. Homocysteine thiolactone contributes to a prognostic value of fibrin clot structure/function in coronary artery disease patients
  11. Cystathionine β-synthase gene inactivation dysregulates major urinary protein biogenesis and impairs sexual signaling in mice
  12. Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson’s Disease
  13. COVID-19 and One-Carbon Metabolism
  14. B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment
  15. Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
  16. Changes in redox plasma proteome of Pon1−/− mice are exacerbated by a hyperhomocysteinemic diet
  17. Proteome-Wide Analysis of Protein Lysine N-Homocysteinylation in Saccharomyces cerevisiae
  18. Anti‐ N ‐homocysteine‐protein autoantibodies are associated with impaired cognition
  19. Genetic Attenuation of Paraoxonase 1 Activity Induces Proatherogenic Changes in Plasma Proteomes of Mice and Humans
  20. Telomere Length and mtDNA Copy Number in Human Cystathionine β-synthase Deficiency
  21. Cystathionine β-synthase deficiency: different changes in proteomes of thrombosis-resistant Cbs−/− mice and thrombosis-prone CBS−/− humans
  22. Quantification of homocysteine thiolactone in human saliva and urine by gas chromatography-mass spectrometry
  23. Copper, heart disease and homocysteine thiolactone
  24. The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice
  25. The Multispecies Probiotic Effectively Reduces Homocysteine Concentration in Obese Women: A Randomized Double-Blind Placebo-Controlled Study
  26. Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice
  27. Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia
  28. Serum Proteome Alterations in Human Cystathionine β-Synthase Deficiency and Ischemic Stroke Subtypes
  29. Sex affects N-homocysteinylation at lysine residue 212 of albumin in mice
  30. Homocysteine Modification in Protein Structure/Function and Human Disease
  31. Protein N-Homocysteinylation and Colorectal Cancer
  32. Mutations in Homocysteine Metabolism Genes Increase Keratin N-Homocysteinylation and Damage in Mice
  33. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
  34. Garlic extract favorably modifies markers of endothelial function in obese patients –randomized double blind placebo-controlled nutritional intervention
  35. Genetic variation in paraoxonase 1 and homocysteine thiolactone accumulation in humans
  36. Demethylation of methionine and keratin damage in human hair
  37. Homocysteine Editing, Thioester Chemistry, Coenzyme A, and the Origin of Coded Peptide Synthesis †
  38. Simultaneous Determination of Methionine and Homocysteine by on-column derivatization with o -phtaldialdehyde
  39. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice
  40. Methylfolate Trap Promotes Bacterial Thymineless Death by Sulfa Drugs
  41. Quantification of urinary S- and N-homocysteinylated protein and homocysteine-thiolactone in mice
  42. Connective tissue damage by homocysteine
  43. Effects of endurance and endurance–strength exercise on biochemical parameters of liver function in women with abdominal obesity
  44. Aminoacyl-tRNA synthetases and the evolution of coded peptide synthesis: the Thioester World
  45. Quantification of homocysteine and cysteine by derivatization with pyridoxal 5'-phosphate and hydrophilic interaction liquid chromatography
  46. l -Arginine and vitamin C attenuate pro-atherogenic effects of high-fat diet on biomarkers of endothelial dysfunction in rats
  47. Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells
  48. Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease
  49. The influence of selected antihypertensive drugs on zinc, copper, and iron status in spontaneously hypertensive rats
  50. Labeled EF-Tus for Rapid Kinetic Studies of Pretranslocation Complex Formation
  51. Inactivation of the Paraoxonase 1 Gene Affects the Expression of Mouse Brain Proteins Involved in Neurodegeneration
  52. Methionine-induced hyperhomocysteinemia and bleomycin hydrolase deficiency alter the expression of mouse kidney proteins involved in renal disease
  53. Hyperhomocysteinemia and Bleomycin Hydrolase Modulate the Expression of Mouse Brain Proteins Involved in Neurodegeneration
  54. Bleomycin hydrolase and hyperhomocysteinemia modulate the expression of mouse proteins involved in liver homeostasis
  55. Identification of N-homocysteinylation sites in plasma proteins
  56. Effects of betaine on body composition, performance, and homocysteine thiolactone
  57. Correction
  58. The Mechanism and Consequences of Homocysteine Incorporation Into Protein in Humans
  59. Design and properties of efficient tRNA:EF-Tu FRET system for studies of ribosomal translation
  60. Homocysteine in Protein Structure/Function and Human Disease
  61. N-homocysteinylation of ovine prion protein induces amyloid-like transformation
  62. Paraoxonase 1 and homocysteine metabolism
  63. Metabolism and Neurotoxicity of Homocysteine Thiolactone in Mice: Evidence for a Protective Role of Paraoxonase 1
  64. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase
  65. Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension
  66. Quality control in tRNA charging
  67. Aggregation and structural changes of αS1-, β- and κ-caseins induced by homocysteinylation
  68. Cation exchange HPLC analysis of desmosines in elastin hydrolysates
  69. Analysis of site-specific N-homocysteinylation of human serum albumin in vitro and in vivo using MALDI-ToF and LC-MS/MS mass spectrometry
  70. Chemical Biology of Homocysteine Thiolactone and Related Metabolites
  71. Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation
  72. Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry
  73. Identification and origin of Nε-homocysteinyl-lysine isopeptide in humans and mice
  74. Reduced Homocysteine-Thiolactonase Activity in Alzheimer's Disease
  75. An on-column derivatization method for the determination of homocysteine-thiolactone and protein N-linked homocysteine
  76. On-column derivatization with o-phthaldialdehyde for fast determination of homocysteine in human urine
  77. Properties of Escherichia coli EF-Tu mutants designed for fluorescence resonance energy transfer from tRNA molecules
  78. The Role of Paraoxonase 1 in the Detoxification of Homocysteine Thiolactone
  79. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat
  80. Paraoxonase 1 protects against protein N-homocysteinylation in humans
  81. Homocysteine editing and growth inhibition in Escherichia coli
  82. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice
  83. Role of homocysteine in aortic calcification and osteogenic cell differentiation
  84. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice
  85. New method for the determination of protein N-linked homocysteine
  86. Mutations in cystathionine  -synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans
  87. Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients
  88. Fluorescence enhancement on silver nanostructures: studies of components of ribosomal translation in vitro
  89. Facile syntheses of [35S]homocysteine-thiolactone, [35S]homocystine, [35S]homocysteine, and [S-nitroso-35S]homocysteine
  90. Differential Regulation of Homocysteine Transport in Vascular Endothelial and Smooth Muscle Cells
  91. Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency
  92. Modification by Homocysteine Thiolactone Affects Redox Status of Cytochromec
  93. Mutations in methylenetetrahydrofolate reductase or cystathionine  -syntase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice
  94. Mechanisms of homocysteine toxicity in humans
  95. The molecular basis of homocysteine thiolactone-mediated vascular disease
  96. Mechanism of the Condensation of Homocysteine Thiolactone with Aldehydes
  97. Letter by Undas and Jakubowski Regarding Article, “Relationship Between Homocysteine and Mortality in Chronic Kidney Disease”
  98. Protective Mechanisms against Homocysteine Toxicity
  99. Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects
  100. Synergistic, Random Sequential Binding of Substrates in Cobalamin-Independent Methionine Synthase†
  101. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia
  102. The determination of homocysteine–thiolactone in human plasma
  103. Urinary Excretion of Homocysteine-Thiolactone in Humans
  104. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease
  105. Antibodies to N-homocysteinylated albumin as a marker for earlyonset coronary artery disease in men
  106. The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols
  107. Purification of antibodies against N-homocysteinylated proteins by affinity chromatography on Nω-homocysteinyl-aminohexyl-Agarose
  108. Autoantibodies Against N -Homocysteinylated Proteins in Humans
  109. Molecular basis of homocysteine toxicity in humans
  110. Cross-talk between Cys34and Lysine Residues in Human Serum Albumin Revealed byN-Homocysteinylation
  111. On the health benefits of Allium sp.
  112. Homocysteine-Thiolactone and S-Nitroso-Homocysteine Mediate Incorporation of Homocysteine into Protein in Humans
  113. Metabolism of Homocysteine-thiolactone in Plants
  114. Genomic Association/Linkage of Sodium Lithium Countertransport in CEPH Pedigrees
  115. The determination of homocysteine-thiolactone in biological samples
  116. Homocysteine Is a Protein Amino Acid in Humans
  117. Protein N-homocysteinylation: implications for atherosclerosis
  118. Yeast cytoplasmic and mitochondrial methionyl-tRNA synthetases: two structural frameworks for identical functions
  119. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis
  120. Amino Acid Selectivity in the Aminoacylation of Coenzyme A and RNA Minihelices by Aminoacyl-tRNA Synthetases
  121. Homocysteine Thiolactone and Protein Homocysteinylation in Human Endothelial Cells
  122. Translational Incorporation ofS-Nitrosohomocysteine into Protein
  123. Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
  124. Misacylation of tRNALyswith Noncognate Amino Acids by Lysyl-tRNA Synthetase†
  125. Aminoacylation of Coenzyme A and Pantetheine by Aminoacyl-tRNA Synthetases:  Possible Link between Noncoded and Coded Peptide Synthesis†
  126. Aminoacyl Thioester Chemistry of Class II Aminoacyl-tRNA Synthetases†
  127. Proofreading in trans by an aminoacyl-tRNA synthetase: a model for single site editing by isoleucyl-tRNA synthetase
  128. The Synthetic/Editing Active Site of an Aminoacyl-tRNA Synthetase:  Evidence for Binding of Thiols in the Editing Subsite†
  129. Evidence that Uncharged tRNA Can Inhibit a Programmed Translational Frameshift inEscherichia coli
  130. Proofreadingin Vivo
  131. Synthesis of cysteine-containing dipeptides by aminpacyl-tRNAsynthetases
  132. Role of carboxy-terminal region in proofreading function of methionyl-tRNA synthetase in Escherichia coli
  133. Editing function ofEscherichia coli cysteinyl-tRNA synthetase: cyclization of cysteine to cysteine thiolactone
  134. Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells
  135. Role of the metF and metJ genes on the vitamin B12 regulation of methionine gene expression: Involvement of N5-methyltetrahydrofolic acid
  136. Relationship between protein synthesis and concentrations of charged and uncharged tRNATrp in Escherichia coli.
  137. Negative correlation between the abundance of Escherichia coli aminoacyl-tRNA families and their affinities for elongation factor Tu-GTP
  138. Synthesis of diadenosine 5',5'''-P1,P4-tetraphosphate (AppppA) from adenosine 5'-phosphosulfate and adenosine 5'-triphosphate catalyzed by yeast AppppA phosphorylase
  139. Phosphonate analogs of diadenosine 5',5'''-P1,P4-tetraphosphate as substrates or inhibitors of prokaryotic and eukaryotic enzymes degrading dinucloside tetraphosphates
  140. Adenosylhomocysteinase from yellow lupine
  141. Control of RNA and protein synthesis by the concentration of Trp-tRNATrp in Escherichia coli infected with bacteriophage MS2
  142. Substrate specificity of S-Adenosylhomocysteinase
  143. The mechanism of inhibition of valyl-tRNA synthetase by S-adenosylhomocysteine
  144. S-Adenosylhomocysteinase from yellow lupine seeds: stoichiometry and reactions of the enzyme.cntdot.adenosine complex
  145. Alternative pathways for editing non-cognate amino acids by aminoacyl-tRNA synthetases
  146. Valyl-tRNA synthetase from yellow lupin seeds: hydrolysis of the enzyme-bound noncognate aminoacyl adenylate as a possible mechanism of increasing specificity of the aminoacyl-tRNA synthetase
  147. Polyamines and yellow lupin aminoacyl-tRNA synthetases
  148. A role for protein-protein interactions in the maintenance of active forms of aminoacyl-tRNA synthetases
  149. Yellow lupin (Lupinus luteus) aminoacyl-tRNA synthetases
  150. Valyl-tRNA synthetase from yellow lupin seeds
  151. Adenosylhomocysteinase:Adenosine complex
  152. The mechanism of the aminoacylation of transfer ribonucleic acid The kinetics and stoichiometry of the lysis of aminoacyl-tRNA
  153. Incomplete aminoacylation of tRNALeu catalyzed in vitro by leucyl-tRNA synthetase from Escherichia coli B
  154. The determination of aminoacyl adenylate by thin-layer chromatography
  155. Use of ω-aminohexyl-sepharose in the fractionation of escherichia coli B aminoacyl-tRNA synthetases
  156. Fractionation of plant aminoacyl-tRNA synthetases on tRNA-sepharose columns
  157. The Plant Aminoacyl-tRNA Synthetases. Purification and Characterization of Valyl-tRNA, Tryptophanyl-tRNA and Seryl-tRNA Synthetases from Yellow-Lupin Seeds
  158. Transfer RNA methyltransferases from yellow lupin seeds: purification and properties
  159. ω-Aminohexyl-Sepharose 4B, a new support for tRNA fractionation
  160. Chromatography of plant aminoacyl-tRNA synthetases on ω-aminoalkyl sepharose columns
  161. Homocysteine Metabolism and Pathological Implications: The Homocysteine Thiolactone Hypothesis of Vascular Disease